Bowhead Specialty Holdings Inc. (NYSE:BOW - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six analysts that are covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $39.67.
A number of analysts have recently weighed in on BOW shares. Piper Sandler started coverage on shares of Bowhead Specialty in a research report on Wednesday, April 16th. They set an "overweight" rating and a $44.00 price target for the company. Morgan Stanley raised their price objective on shares of Bowhead Specialty from $36.00 to $39.00 and gave the stock an "equal weight" rating in a report on Monday, May 19th. Keefe, Bruyette & Woods raised their price objective on shares of Bowhead Specialty from $43.00 to $45.00 and gave the stock an "outperform" rating in a report on Friday, May 9th. JMP Securities raised their price objective on shares of Bowhead Specialty from $38.00 to $40.00 and gave the stock a "market outperform" rating in a report on Friday, April 11th. Finally, JPMorgan Chase & Co. lifted their price target on Bowhead Specialty from $30.00 to $35.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 8th.
Check Out Our Latest Stock Analysis on Bowhead Specialty
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of the business. The Manufacturers Life Insurance Company boosted its holdings in shares of Bowhead Specialty by 0.8% in the 4th quarter. The Manufacturers Life Insurance Company now owns 60,963 shares of the company's stock valued at $2,165,000 after buying an additional 455 shares during the period. Summit Investment Advisors Inc. boosted its stake in Bowhead Specialty by 66.4% in the fourth quarter. Summit Investment Advisors Inc. now owns 1,218 shares of the company's stock valued at $43,000 after acquiring an additional 486 shares during the period. Sei Investments Co. boosted its stake in Bowhead Specialty by 0.8% in the fourth quarter. Sei Investments Co. now owns 94,395 shares of the company's stock valued at $3,353,000 after acquiring an additional 760 shares during the period. SBI Securities Co. Ltd. acquired a new position in Bowhead Specialty during the 1st quarter valued at approximately $44,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Bowhead Specialty by 17.5% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,400 shares of the company's stock valued at $301,000 after purchasing an additional 1,100 shares during the period.
Bowhead Specialty Price Performance
BOW traded up $0.28 during trading hours on Thursday, reaching $36.30. 137,919 shares of the stock traded hands, compared to its average volume of 198,995. The firm's fifty day simple moving average is $38.80 and its two-hundred day simple moving average is $36.07. The company has a market cap of $1.19 billion and a price-to-earnings ratio of 27.71. Bowhead Specialty has a fifty-two week low of $23.70 and a fifty-two week high of $42.29.
Bowhead Specialty (NYSE:BOW - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.01. The business had revenue of $174.85 million for the quarter, compared to analyst estimates of $105.17 million. On average, research analysts predict that Bowhead Specialty will post 1.36 earnings per share for the current year.
About Bowhead Specialty
(
Get Free ReportBowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Featured Stories

Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.